Clover Health Investments, Corp. reported $2.48B of revenue over the trailing twelve months, +54% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $2.48B (to Q2 2026). Free cash flow: $74M, trailing twelve months to Q2 2026. Operating margin: −1.9%, trailing twelve months to Q2 2026. EPS: −$0.05, trailing twelve months to Q2 2026.

CLOVClover Health Investments, Corp.

Healthcare

$4.80+58% 1Y

$4.80

$1.7052 weeks$5.21

CLOV as reported

Clover Health Investments, Corp. reported $2.48B of revenue over the trailing twelve months, +54% on the year before. 10 reported series are charted on this page, each one as filed.

$2.48B

Revenue, trailing twelve months · to Q2 2026 · +54% against the twelve months before

Free cash flow: $74M
Free cash flow · −254% year on year · trailing twelve months to Q2 2026
Operating margin: −1.9%
Operating margin · trailing twelve months to Q2 2026
EPS: −$0.05
EPS · −37% year on year · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for CLOV, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$2.48B	+54%	Q2 2026
Net income	−$91M	n/a	Q3 2024 · 7 quarters behind
EPS	−$0.05	−37%	Q2 2026
Gross margin	25%	n/a	Q3 2024 · 7 quarters behind
Operating margin	−1.9%	n/a	Q2 2026
Net margin	−7.2%	n/a	Q3 2024 · 7 quarters behind
ROE	−48%	n/a	Q3 2024 · 7 quarters behind
ROA	−23%	n/a	Q3 2024 · 7 quarters behind
ROIC	−349%	n/a	Q4 2022 · 14 quarters behind
Free cash flow	$74M	−254%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.